Keyphrases
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Asthma
41%
Death-associated Protein Kinase 1 (DAPK1)
36%
Independent Prognostic Factor
35%
Idiopathic Cytopenia of Undetermined Significance
33%
Poor Outcome
33%
Cell-free DNA (cfDNA)
30%
TP53 mutation
22%
Lymphoma Patients
22%
Rhinitis
21%
SNP
20%
Myelodysplastic Syndrome
20%
Dysplastic Changes
18%
Asthmatic
17%
Overall Survival
16%
MicroRNA
16%
Survival Prediction
16%
Factors Predicting
16%
Tumor Suppressor miRNA
16%
Azacitidine
16%
Sequence Variants
16%
Female Reproductive Organs
16%
Genetic Status
16%
Bone Marrow Biopsy
16%
Vitamin C Supplementation
16%
Aberrant Methylation
16%
Long-term Clinical Outcome
16%
Plasma Vitamin C
16%
Splicing mutation
16%
Myeloid Cancer
16%
5-hydroxymethylcytosine (5hmC)
16%
Positron Emission Tomography Combined with Computed Tomography
16%
Hypermethylation
16%
Prognostic Factors
16%
Large Group
16%
Eosinophils
16%
Canadian Studies
16%
Cytopenia
16%
Rituximab Era
16%
Prognostic Role
16%
Mantle Cell Lymphoma
16%
R-IPI
16%
Routine Assessment
16%
Treatment Strategy
16%
Organ Involvement
16%
Epigenetic Modification
16%
YKL-40
16%
Single-center Study
16%
Flow Cytometry
16%
Central Nervous System Involvement
16%
Biochemistry, Genetics and Molecular Biology
Methylation
50%
B Cell
50%
Myeloid
43%
DAPK1
33%
Single Nucleotide Polymorphism
21%
Blood Plasma
20%
Epigenetics
20%
MicroRNA
16%
Gene Linkage
16%
All Cause Mortality
16%
Mutated Genes
16%
Vitamin C
16%
Spliceosome
16%
Comorbidity
16%
Vitamin Blood Level
16%
ICD-10
16%
Population
16%
Tumor Suppressor Protein
16%
Azacitidine
16%
Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
66%
Cytopenia
33%
Rituximab
24%
Diagnosis
23%
Overall Survival
19%
Malignant Neoplasm
19%
Positron Emission Tomography-Computed Tomography
18%
Central Nervous System
16%
Mantle Cell Lymphoma
16%
Reproductive Organ
16%
Supplementation
16%
positron emission tomographic scan
16%
Ascorbic Acid
16%
Flow Cytometry
16%
Bone Marrow Biopsy
16%
Azacitidine
16%
Prognosis
16%
Prognostic Factor
16%
Computer Assisted Tomography
16%
